23-Valent Pneumococcal Polysaccharide Vaccine Market - Global Outlook and Forecast 2021-2027
This report contains market size and forecasts of 23-Valent Pneumococcal Polysaccharide Vaccine in global, including the following market information:
Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Sales, 2016-2021, 2022-2027, (K Dose)
Global top five 23-Valent Pneumococcal Polysaccharide Vaccine companies in 2020 (%)
The global 23-Valent Pneumococcal Polysaccharide Vaccine market was valued at 2447 million in 2020 and is projected to reach US$ 4101.3 million by 2027, at a CAGR of 13.8% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the 23-Valent Pneumococcal Polysaccharide Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global 23-Valent Pneumococcal Polysaccharide Vaccine Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Dose)
Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Segment Percentages, By Type, 2020 (%)
Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Segment Percentages, By Application, 2020 (%)
Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Segment Percentages, By Region and Country, 2020 (%)
The report also provides analysis of leading market participants including:
Key companies 23-Valent Pneumococcal Polysaccharide Vaccine revenues in global market, 2016-2021 (Estimated), ($ millions)
Key companies 23-Valent Pneumococcal Polysaccharide Vaccine revenues share in global market, 2020 (%)
Key companies 23-Valent Pneumococcal Polysaccharide Vaccine sales in global market, 2016-2021 (Estimated), (K Dose)
Key companies 23-Valent Pneumococcal Polysaccharide Vaccine sales share in global market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:
Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Sales, 2016-2021, 2022-2027, (K Dose)
Global top five 23-Valent Pneumococcal Polysaccharide Vaccine companies in 2020 (%)
The global 23-Valent Pneumococcal Polysaccharide Vaccine market was valued at 2447 million in 2020 and is projected to reach US$ 4101.3 million by 2027, at a CAGR of 13.8% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the 23-Valent Pneumococcal Polysaccharide Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global 23-Valent Pneumococcal Polysaccharide Vaccine Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Dose)
Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Segment Percentages, By Type, 2020 (%)
- Single Dose Vial
- Pre-filled Syringe
Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Segment Percentages, By Application, 2020 (%)
- For Children (2-10)
- For Person (10-64)
- For The Old (?65)
Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Segment Percentages, By Region and Country, 2020 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies 23-Valent Pneumococcal Polysaccharide Vaccine revenues in global market, 2016-2021 (Estimated), ($ millions)
Key companies 23-Valent Pneumococcal Polysaccharide Vaccine revenues share in global market, 2020 (%)
Key companies 23-Valent Pneumococcal Polysaccharide Vaccine sales in global market, 2016-2021 (Estimated), (K Dose)
Key companies 23-Valent Pneumococcal Polysaccharide Vaccine sales share in global market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:
- MSD
- Sanofipasteur
- CDIBP
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 23-Valent Pneumococcal Polysaccharide Vaccine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL 23-VALENT PNEUMOCOCCAL POLYSACCHARIDE VACCINE OVERALL MARKET SIZE
2.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size: 2021 VS 2027
2.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue, Prospects & Forecasts: 2016-2027
2.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales (Consumption): 2016-2027
3 COMPANY LANDSCAPE
3.1 Top 23-Valent Pneumococcal Polysaccharide Vaccine Players in Global Market
3.2 Top Global 23-Valent Pneumococcal Polysaccharide Vaccine Companies Ranked by Revenue
3.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Companies
3.4 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Companies
3.5 Global 23-Valent Pneumococcal Polysaccharide Vaccine Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 23-Valent Pneumococcal Polysaccharide Vaccine Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers 23-Valent Pneumococcal Polysaccharide Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 23-Valent Pneumococcal Polysaccharide Vaccine Players in Global Market
3.8.1 List of Global Tier 1 23-Valent Pneumococcal Polysaccharide Vaccine Companies
3.8.2 List of Global Tier 2 and Tier 3 23-Valent Pneumococcal Polysaccharide Vaccine Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size Markets, 2021 & 2027
4.1.2 Single Dose Vial
4.1.3 Pre-filled Syringe
4.2 By Type - Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue & Forecasts
4.2.1 By Type - Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue, 2016-2021
4.2.2 By Type - Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue, 2022-2027
4.2.3 By Type - Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share, 2016-2027
4.3 By Type - Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales & Forecasts
4.3.1 By Type - Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales, 2016-2021
4.3.2 By Type - Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales, 2022-2027
4.3.3 By Type - Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share, 2016-2027
4.4 By Type - Global 23-Valent Pneumococcal Polysaccharide Vaccine Price (Manufacturers Selling Prices), 2016-2027
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size, 2021 & 2027
5.1.2 For Children (2-10)
5.1.3 For Person (10-64)
5.1.4 For The Old (?65)
5.2 By Application - Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue & Forecasts
5.2.1 By Application - Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue, 2016-2021
5.2.2 By Application - Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue, 2022-2027
5.2.3 By Application - Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share, 2016-2027
5.3 By Application - Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales & Forecasts
5.3.1 By Application - Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales, 2016-2021
5.3.2 By Application - Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales, 2022-2027
5.3.3 By Application - Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share, 2016-2027
5.4 By Application - Global 23-Valent Pneumococcal Polysaccharide Vaccine Price (Manufacturers Selling Prices), 2016-2027
6 SIGHTS BY REGION
6.1 By Region - Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size, 2021 & 2027
6.2 By Region - Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue & Forecasts
6.2.1 By Region - Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue, 2016-2021
6.2.2 By Region - Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue, 2022-2027
6.2.3 By Region - Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share, 2016-2027
6.3 By Region - Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales & Forecasts
6.3.1 By Region - Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales, 2016-2021
6.3.2 By Region - Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales, 2022-2027
6.3.3 By Region - Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share, 2016-2027
6.4 North America
6.4.1 By Country - North America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue, 2016-2027
6.4.2 By Country - North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales, 2016-2027
6.4.3 US 23-Valent Pneumococcal Polysaccharide Vaccine Market Size, 2016-2027
6.4.4 Canada 23-Valent Pneumococcal Polysaccharide Vaccine Market Size, 2016-2027
6.4.5 Mexico 23-Valent Pneumococcal Polysaccharide Vaccine Market Size, 2016-2027
6.5 Europe
6.5.1 By Country - Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue, 2016-2027
6.5.2 By Country - Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales, 2016-2027
6.5.3 Germany 23-Valent Pneumococcal Polysaccharide Vaccine Market Size, 2016-2027
6.5.4 France 23-Valent Pneumococcal Polysaccharide Vaccine Market Size, 2016-2027
6.5.5 U.K. 23-Valent Pneumococcal Polysaccharide Vaccine Market Size, 2016-2027
6.5.6 Italy 23-Valent Pneumococcal Polysaccharide Vaccine Market Size, 2016-2027
6.5.7 Russia 23-Valent Pneumococcal Polysaccharide Vaccine Market Size, 2016-2027
6.5.8 Nordic Countries 23-Valent Pneumococcal Polysaccharide Vaccine Market Size, 2016-2027
6.5.9 Benelux 23-Valent Pneumococcal Polysaccharide Vaccine Market Size, 2016-2027
6.6 Asia
6.6.1 By Region - Asia 23-Valent Pneumococcal Polysaccharide Vaccine Revenue, 2016-2027
6.6.2 By Region - Asia 23-Valent Pneumococcal Polysaccharide Vaccine Sales, 2016-2027
6.6.3 China 23-Valent Pneumococcal Polysaccharide Vaccine Market Size, 2016-2027
6.6.4 Japan 23-Valent Pneumococcal Polysaccharide Vaccine Market Size, 2016-2027
6.6.5 South Korea 23-Valent Pneumococcal Polysaccharide Vaccine Market Size, 2016-2027
6.6.6 Southeast Asia 23-Valent Pneumococcal Polysaccharide Vaccine Market Size, 2016-2027
6.6.7 India 23-Valent Pneumococcal Polysaccharide Vaccine Market Size, 2016-2027
6.7 South America
6.7.1 By Country - South America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue, 2016-2027
6.7.2 By Country - South America 23-Valent Pneumococcal Polysaccharide Vaccine Sales, 2016-2027
6.7.3 Brazil 23-Valent Pneumococcal Polysaccharide Vaccine Market Size, 2016-2027
6.7.4 Argentina 23-Valent Pneumococcal Polysaccharide Vaccine Market Size, 2016-2027
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue, 2016-2027
6.8.2 By Country - Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales, 2016-2027
6.8.3 Turkey 23-Valent Pneumococcal Polysaccharide Vaccine Market Size, 2016-2027
6.8.4 Israel 23-Valent Pneumococcal Polysaccharide Vaccine Market Size, 2016-2027
6.8.5 Saudi Arabia 23-Valent Pneumococcal Polysaccharide Vaccine Market Size, 2016-2027
6.8.6 UAE 23-Valent Pneumococcal Polysaccharide Vaccine Market Size, 2016-2027
7 MANUFACTURERS & BRANDS PROFILES
7.1 MSD
7.1.1 MSD Corporate Summary
7.1.2 MSD Business Overview
7.1.3 MSD 23-Valent Pneumococcal Polysaccharide Vaccine Major Product Offerings
7.1.4 MSD 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Revenue in Global (2016-2021)
7.1.5 MSD Key News
7.2 Sanofipasteur
7.2.1 Sanofipasteur Corporate Summary
7.2.2 Sanofipasteur Business Overview
7.2.3 Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Major Product Offerings
7.2.4 Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Revenue in Global (2016-2021)
7.2.5 Sanofipasteur Key News
7.3 CDIBP
7.3.1 CDIBP Corporate Summary
7.3.2 CDIBP Business Overview
7.3.3 CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Major Product Offerings
7.3.4 CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Revenue in Global (2016-2021)
7.3.5 CDIBP Key News
8 GLOBAL 23-VALENT PNEUMOCOCCAL POLYSACCHARIDE VACCINE PRODUCTION CAPACITY, ANALYSIS
8.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Production Capacity, 2016-2027
8.2 23-Valent Pneumococcal Polysaccharide Vaccine Production Capacity of Key Manufacturers in Global Market
8.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 23-VALENT PNEUMOCOCCAL POLYSACCHARIDE VACCINE SUPPLY CHAIN ANALYSIS
10.1 23-Valent Pneumococcal Polysaccharide Vaccine Industry Value Chain
10.2 23-Valent Pneumococcal Polysaccharide Vaccine Upstream Market
10.3 23-Valent Pneumococcal Polysaccharide Vaccine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 23-Valent Pneumococcal Polysaccharide Vaccine Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
1.1 23-Valent Pneumococcal Polysaccharide Vaccine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL 23-VALENT PNEUMOCOCCAL POLYSACCHARIDE VACCINE OVERALL MARKET SIZE
2.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size: 2021 VS 2027
2.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue, Prospects & Forecasts: 2016-2027
2.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales (Consumption): 2016-2027
3 COMPANY LANDSCAPE
3.1 Top 23-Valent Pneumococcal Polysaccharide Vaccine Players in Global Market
3.2 Top Global 23-Valent Pneumococcal Polysaccharide Vaccine Companies Ranked by Revenue
3.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Companies
3.4 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Companies
3.5 Global 23-Valent Pneumococcal Polysaccharide Vaccine Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 23-Valent Pneumococcal Polysaccharide Vaccine Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers 23-Valent Pneumococcal Polysaccharide Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 23-Valent Pneumococcal Polysaccharide Vaccine Players in Global Market
3.8.1 List of Global Tier 1 23-Valent Pneumococcal Polysaccharide Vaccine Companies
3.8.2 List of Global Tier 2 and Tier 3 23-Valent Pneumococcal Polysaccharide Vaccine Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size Markets, 2021 & 2027
4.1.2 Single Dose Vial
4.1.3 Pre-filled Syringe
4.2 By Type - Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue & Forecasts
4.2.1 By Type - Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue, 2016-2021
4.2.2 By Type - Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue, 2022-2027
4.2.3 By Type - Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share, 2016-2027
4.3 By Type - Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales & Forecasts
4.3.1 By Type - Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales, 2016-2021
4.3.2 By Type - Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales, 2022-2027
4.3.3 By Type - Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share, 2016-2027
4.4 By Type - Global 23-Valent Pneumococcal Polysaccharide Vaccine Price (Manufacturers Selling Prices), 2016-2027
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size, 2021 & 2027
5.1.2 For Children (2-10)
5.1.3 For Person (10-64)
5.1.4 For The Old (?65)
5.2 By Application - Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue & Forecasts
5.2.1 By Application - Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue, 2016-2021
5.2.2 By Application - Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue, 2022-2027
5.2.3 By Application - Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share, 2016-2027
5.3 By Application - Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales & Forecasts
5.3.1 By Application - Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales, 2016-2021
5.3.2 By Application - Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales, 2022-2027
5.3.3 By Application - Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share, 2016-2027
5.4 By Application - Global 23-Valent Pneumococcal Polysaccharide Vaccine Price (Manufacturers Selling Prices), 2016-2027
6 SIGHTS BY REGION
6.1 By Region - Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size, 2021 & 2027
6.2 By Region - Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue & Forecasts
6.2.1 By Region - Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue, 2016-2021
6.2.2 By Region - Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue, 2022-2027
6.2.3 By Region - Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share, 2016-2027
6.3 By Region - Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales & Forecasts
6.3.1 By Region - Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales, 2016-2021
6.3.2 By Region - Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales, 2022-2027
6.3.3 By Region - Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share, 2016-2027
6.4 North America
6.4.1 By Country - North America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue, 2016-2027
6.4.2 By Country - North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales, 2016-2027
6.4.3 US 23-Valent Pneumococcal Polysaccharide Vaccine Market Size, 2016-2027
6.4.4 Canada 23-Valent Pneumococcal Polysaccharide Vaccine Market Size, 2016-2027
6.4.5 Mexico 23-Valent Pneumococcal Polysaccharide Vaccine Market Size, 2016-2027
6.5 Europe
6.5.1 By Country - Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue, 2016-2027
6.5.2 By Country - Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales, 2016-2027
6.5.3 Germany 23-Valent Pneumococcal Polysaccharide Vaccine Market Size, 2016-2027
6.5.4 France 23-Valent Pneumococcal Polysaccharide Vaccine Market Size, 2016-2027
6.5.5 U.K. 23-Valent Pneumococcal Polysaccharide Vaccine Market Size, 2016-2027
6.5.6 Italy 23-Valent Pneumococcal Polysaccharide Vaccine Market Size, 2016-2027
6.5.7 Russia 23-Valent Pneumococcal Polysaccharide Vaccine Market Size, 2016-2027
6.5.8 Nordic Countries 23-Valent Pneumococcal Polysaccharide Vaccine Market Size, 2016-2027
6.5.9 Benelux 23-Valent Pneumococcal Polysaccharide Vaccine Market Size, 2016-2027
6.6 Asia
6.6.1 By Region - Asia 23-Valent Pneumococcal Polysaccharide Vaccine Revenue, 2016-2027
6.6.2 By Region - Asia 23-Valent Pneumococcal Polysaccharide Vaccine Sales, 2016-2027
6.6.3 China 23-Valent Pneumococcal Polysaccharide Vaccine Market Size, 2016-2027
6.6.4 Japan 23-Valent Pneumococcal Polysaccharide Vaccine Market Size, 2016-2027
6.6.5 South Korea 23-Valent Pneumococcal Polysaccharide Vaccine Market Size, 2016-2027
6.6.6 Southeast Asia 23-Valent Pneumococcal Polysaccharide Vaccine Market Size, 2016-2027
6.6.7 India 23-Valent Pneumococcal Polysaccharide Vaccine Market Size, 2016-2027
6.7 South America
6.7.1 By Country - South America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue, 2016-2027
6.7.2 By Country - South America 23-Valent Pneumococcal Polysaccharide Vaccine Sales, 2016-2027
6.7.3 Brazil 23-Valent Pneumococcal Polysaccharide Vaccine Market Size, 2016-2027
6.7.4 Argentina 23-Valent Pneumococcal Polysaccharide Vaccine Market Size, 2016-2027
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue, 2016-2027
6.8.2 By Country - Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales, 2016-2027
6.8.3 Turkey 23-Valent Pneumococcal Polysaccharide Vaccine Market Size, 2016-2027
6.8.4 Israel 23-Valent Pneumococcal Polysaccharide Vaccine Market Size, 2016-2027
6.8.5 Saudi Arabia 23-Valent Pneumococcal Polysaccharide Vaccine Market Size, 2016-2027
6.8.6 UAE 23-Valent Pneumococcal Polysaccharide Vaccine Market Size, 2016-2027
7 MANUFACTURERS & BRANDS PROFILES
7.1 MSD
7.1.1 MSD Corporate Summary
7.1.2 MSD Business Overview
7.1.3 MSD 23-Valent Pneumococcal Polysaccharide Vaccine Major Product Offerings
7.1.4 MSD 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Revenue in Global (2016-2021)
7.1.5 MSD Key News
7.2 Sanofipasteur
7.2.1 Sanofipasteur Corporate Summary
7.2.2 Sanofipasteur Business Overview
7.2.3 Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Major Product Offerings
7.2.4 Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Revenue in Global (2016-2021)
7.2.5 Sanofipasteur Key News
7.3 CDIBP
7.3.1 CDIBP Corporate Summary
7.3.2 CDIBP Business Overview
7.3.3 CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Major Product Offerings
7.3.4 CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Revenue in Global (2016-2021)
7.3.5 CDIBP Key News
8 GLOBAL 23-VALENT PNEUMOCOCCAL POLYSACCHARIDE VACCINE PRODUCTION CAPACITY, ANALYSIS
8.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Production Capacity, 2016-2027
8.2 23-Valent Pneumococcal Polysaccharide Vaccine Production Capacity of Key Manufacturers in Global Market
8.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 23-VALENT PNEUMOCOCCAL POLYSACCHARIDE VACCINE SUPPLY CHAIN ANALYSIS
10.1 23-Valent Pneumococcal Polysaccharide Vaccine Industry Value Chain
10.2 23-Valent Pneumococcal Polysaccharide Vaccine Upstream Market
10.3 23-Valent Pneumococcal Polysaccharide Vaccine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 23-Valent Pneumococcal Polysaccharide Vaccine Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES
Table 1. Key Players of 23-Valent Pneumococcal Polysaccharide Vaccine in Global Market
Table 2. Top 23-Valent Pneumococcal Polysaccharide Vaccine Players in Global Market, Ranking by Revenue (2019)
Table 3. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Companies, (US$, Mn), 2016-2021
Table 4. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Share by Companies, 2016-2021
Table 5. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Companies, (K Dose), 2016-2021
Table 6. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers 23-Valent Pneumococcal Polysaccharide Vaccine Price (2016-2021) & (USD/Dose)
Table 8. Global Manufacturers 23-Valent Pneumococcal Polysaccharide Vaccine Product Type
Table 9. List of Global Tier 1 23-Valent Pneumococcal Polysaccharide Vaccine Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 23-Valent Pneumococcal Polysaccharide Vaccine Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (US$, Mn), 2016-2021
Table 13. By Type - Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (US$, Mn), 2022-2027
Table 14. By Type - Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose), 2016-2021
Table 15. By Type - Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose), 2022-2027
Table 16. By Application – Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2021 VS 2027
Table 17. By Application - Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (US$, Mn), 2016-2021
Table 18. By Application - Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (US$, Mn), 2022-2027
Table 19. By Application - Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose), 2016-2021
Table 20. By Application - Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose), 2022-2027
Table 21. By Region – Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2021 VS 2027
Table 22. By Region - Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (US$, Mn), 2016-2021
Table 23. By Region - Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (US$, Mn), 2022-2027
Table 24. By Region - Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose), 2016-2021
Table 25. By Region - Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose), 2022-2027
Table 26. By Country - North America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2016-2021
Table 27. By Country - North America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2022-2027
Table 28. By Country - North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales, (K Dose), 2016-2021
Table 29. By Country - North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales, (K Dose), 2022-2027
Table 30. By Country - Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2016-2021
Table 31. By Country - Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2022-2027
Table 32. By Country - Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales, (K Dose), 2016-2021
Table 33. By Country - Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales, (K Dose), 2022-2027
Table 34. By Region - Asia 23-Valent Pneumococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2016-2021
Table 35. By Region - Asia 23-Valent Pneumococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2022-2027
Table 36. By Region - Asia 23-Valent Pneumococcal Polysaccharide Vaccine Sales, (K Dose), 2016-2021
Table 37. By Region - Asia 23-Valent Pneumococcal Polysaccharide Vaccine Sales, (K Dose), 2022-2027
Table 38. By Country - South America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2016-2021
Table 39. By Country - South America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2022-2027
Table 40. By Country - South America 23-Valent Pneumococcal Polysaccharide Vaccine Sales, (K Dose), 2016-2021
Table 41. By Country - South America 23-Valent Pneumococcal Polysaccharide Vaccine Sales, (K Dose), 2022-2027
Table 42. By Country - Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2016-2021
Table 43. By Country - Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2022-2027
Table 44. By Country - Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales, (K Dose), 2016-2021
Table 45. By Country - Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales, (K Dose), 2022-2027
Table 46. MSD Corporate Summary
Table 47. MSD 23-Valent Pneumococcal Polysaccharide Vaccine Product Offerings
Table 48. MSD 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose), Revenue (US$, Mn) and Average Price (USD/Dose) (2016-2021)
Table 49. Sanofipasteur Corporate Summary
Table 50. Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Product Offerings
Table 51. Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose), Revenue (US$, Mn) and Average Price (USD/Dose) (2016-2021)
Table 52. CDIBP Corporate Summary
Table 53. CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Product Offerings
Table 54. CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose), Revenue (US$, Mn) and Average Price (USD/Dose) (2016-2021)
Table 55. 23-Valent Pneumococcal Polysaccharide Vaccine Production Capacity (K Dose) of Key Manufacturers in Global Market, 2019-2021 (K Dose)
Table 56. Global 23-Valent Pneumococcal Polysaccharide Vaccine Capacity Market Share of Key Manufacturers, 2019-2021
Table 57. Global 23-Valent Pneumococcal Polysaccharide Vaccine Production by Region, 2016-2021 (K Dose)
Table 58. Global 23-Valent Pneumococcal Polysaccharide Vaccine Production by Region, 2022-2027 (K Dose)
Table 59. 23-Valent Pneumococcal Polysaccharide Vaccine Market Opportunities & Trends in Global Market
Table 60. 23-Valent Pneumococcal Polysaccharide Vaccine Market Drivers in Global Market
Table 61. 23-Valent Pneumococcal Polysaccharide Vaccine Market Restraints in Global Market
Table 62. 23-Valent Pneumococcal Polysaccharide Vaccine Raw Materials
Table 63. 23-Valent Pneumococcal Polysaccharide Vaccine Raw Materials Suppliers in Global Market
Table 64. Typical 23-Valent Pneumococcal Polysaccharide Vaccine Downstream
Table 65. 23-Valent Pneumococcal Polysaccharide Vaccine Downstream Clients in Global Market
Table 66. 23-Valent Pneumococcal Polysaccharide Vaccine Distributors and Sales Agents in Global Market
Table 1. Key Players of 23-Valent Pneumococcal Polysaccharide Vaccine in Global Market
Table 2. Top 23-Valent Pneumococcal Polysaccharide Vaccine Players in Global Market, Ranking by Revenue (2019)
Table 3. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Companies, (US$, Mn), 2016-2021
Table 4. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Share by Companies, 2016-2021
Table 5. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Companies, (K Dose), 2016-2021
Table 6. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers 23-Valent Pneumococcal Polysaccharide Vaccine Price (2016-2021) & (USD/Dose)
Table 8. Global Manufacturers 23-Valent Pneumococcal Polysaccharide Vaccine Product Type
Table 9. List of Global Tier 1 23-Valent Pneumococcal Polysaccharide Vaccine Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 23-Valent Pneumococcal Polysaccharide Vaccine Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (US$, Mn), 2016-2021
Table 13. By Type - Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (US$, Mn), 2022-2027
Table 14. By Type - Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose), 2016-2021
Table 15. By Type - Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose), 2022-2027
Table 16. By Application – Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2021 VS 2027
Table 17. By Application - Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (US$, Mn), 2016-2021
Table 18. By Application - Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (US$, Mn), 2022-2027
Table 19. By Application - Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose), 2016-2021
Table 20. By Application - Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose), 2022-2027
Table 21. By Region – Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2021 VS 2027
Table 22. By Region - Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (US$, Mn), 2016-2021
Table 23. By Region - Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (US$, Mn), 2022-2027
Table 24. By Region - Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose), 2016-2021
Table 25. By Region - Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose), 2022-2027
Table 26. By Country - North America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2016-2021
Table 27. By Country - North America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2022-2027
Table 28. By Country - North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales, (K Dose), 2016-2021
Table 29. By Country - North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales, (K Dose), 2022-2027
Table 30. By Country - Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2016-2021
Table 31. By Country - Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2022-2027
Table 32. By Country - Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales, (K Dose), 2016-2021
Table 33. By Country - Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales, (K Dose), 2022-2027
Table 34. By Region - Asia 23-Valent Pneumococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2016-2021
Table 35. By Region - Asia 23-Valent Pneumococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2022-2027
Table 36. By Region - Asia 23-Valent Pneumococcal Polysaccharide Vaccine Sales, (K Dose), 2016-2021
Table 37. By Region - Asia 23-Valent Pneumococcal Polysaccharide Vaccine Sales, (K Dose), 2022-2027
Table 38. By Country - South America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2016-2021
Table 39. By Country - South America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2022-2027
Table 40. By Country - South America 23-Valent Pneumococcal Polysaccharide Vaccine Sales, (K Dose), 2016-2021
Table 41. By Country - South America 23-Valent Pneumococcal Polysaccharide Vaccine Sales, (K Dose), 2022-2027
Table 42. By Country - Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2016-2021
Table 43. By Country - Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2022-2027
Table 44. By Country - Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales, (K Dose), 2016-2021
Table 45. By Country - Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales, (K Dose), 2022-2027
Table 46. MSD Corporate Summary
Table 47. MSD 23-Valent Pneumococcal Polysaccharide Vaccine Product Offerings
Table 48. MSD 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose), Revenue (US$, Mn) and Average Price (USD/Dose) (2016-2021)
Table 49. Sanofipasteur Corporate Summary
Table 50. Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Product Offerings
Table 51. Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose), Revenue (US$, Mn) and Average Price (USD/Dose) (2016-2021)
Table 52. CDIBP Corporate Summary
Table 53. CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Product Offerings
Table 54. CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose), Revenue (US$, Mn) and Average Price (USD/Dose) (2016-2021)
Table 55. 23-Valent Pneumococcal Polysaccharide Vaccine Production Capacity (K Dose) of Key Manufacturers in Global Market, 2019-2021 (K Dose)
Table 56. Global 23-Valent Pneumococcal Polysaccharide Vaccine Capacity Market Share of Key Manufacturers, 2019-2021
Table 57. Global 23-Valent Pneumococcal Polysaccharide Vaccine Production by Region, 2016-2021 (K Dose)
Table 58. Global 23-Valent Pneumococcal Polysaccharide Vaccine Production by Region, 2022-2027 (K Dose)
Table 59. 23-Valent Pneumococcal Polysaccharide Vaccine Market Opportunities & Trends in Global Market
Table 60. 23-Valent Pneumococcal Polysaccharide Vaccine Market Drivers in Global Market
Table 61. 23-Valent Pneumococcal Polysaccharide Vaccine Market Restraints in Global Market
Table 62. 23-Valent Pneumococcal Polysaccharide Vaccine Raw Materials
Table 63. 23-Valent Pneumococcal Polysaccharide Vaccine Raw Materials Suppliers in Global Market
Table 64. Typical 23-Valent Pneumococcal Polysaccharide Vaccine Downstream
Table 65. 23-Valent Pneumococcal Polysaccharide Vaccine Downstream Clients in Global Market
Table 66. 23-Valent Pneumococcal Polysaccharide Vaccine Distributors and Sales Agents in Global Market
LIST OF FIGURES
Figure 1. 23-Valent Pneumococcal Polysaccharide Vaccine Segment by Type
Figure 2. 23-Valent Pneumococcal Polysaccharide Vaccine Segment by Application
Figure 3. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue, 2016-2027 (US$, Mn)
Figure 7. 23-Valent Pneumococcal Polysaccharide Vaccine Sales in Global Market: 2016-2027 (K Dose)
Figure 8. The Top 3 and 5 Players Market Share by 23-Valent Pneumococcal Polysaccharide Vaccine Revenue in 2020
Figure 9. By Type - Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share, 2016-2027
Figure 10. By Type - Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share, 2016-2027
Figure 11. By Type - Global 23-Valent Pneumococcal Polysaccharide Vaccine Price (USD/Dose), 2016-2027
Figure 12. By Application - Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share, 2016-2027
Figure 13. By Application - Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share, 2016-2027
Figure 14. By Application - Global 23-Valent Pneumococcal Polysaccharide Vaccine Price (USD/Dose), 2016-2027
Figure 15. By Region - Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share, 2016-2027
Figure 16. By Region - Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share, 2016-2027
Figure 17. By Country - North America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share, 2016-2027
Figure 18. By Country - North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share, 2016-2027
Figure 19. US 23-Valent Pneumococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2016-2027
Figure 20. Canada 23-Valent Pneumococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2016-2027
Figure 21. Mexico 23-Valent Pneumococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2016-2027
Figure 22. By Country - Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share, 2016-2027
Figure 23. By Country - Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share, 2016-2027
Figure 24. Germany 23-Valent Pneumococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2016-2027
Figure 25. France 23-Valent Pneumococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2016-2027
Figure 26. U.K. 23-Valent Pneumococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2016-2027
Figure 27. Italy 23-Valent Pneumococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2016-2027
Figure 28. Russia 23-Valent Pneumococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2016-2027
Figure 29. Nordic Countries 23-Valent Pneumococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2016-2027
Figure 30. Benelux 23-Valent Pneumococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2016-2027
Figure 31. By Region - Asia 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share, 2016-2027
Figure 32. By Region - Asia 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share, 2016-2027
Figure 33. China 23-Valent Pneumococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2016-2027
Figure 34. Japan 23-Valent Pneumococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2016-2027
Figure 35. South Korea 23-Valent Pneumococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2016-2027
Figure 36. Southeast Asia 23-Valent Pneumococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2016-2027
Figure 37. India 23-Valent Pneumococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2016-2027
Figure 38. By Country - South America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share, 2016-2027
Figure 39. By Country - South America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share, 2016-2027
Figure 40. Brazil 23-Valent Pneumococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2016-2027
Figure 41. Argentina 23-Valent Pneumococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2016-2027
Figure 42. By Country - Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share, 2016-2027
Figure 43. By Country - Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share, 2016-2027
Figure 44. Turkey 23-Valent Pneumococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2016-2027
Figure 45. Israel 23-Valent Pneumococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2016-2027
Figure 46. Saudi Arabia 23-Valent Pneumococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2016-2027
Figure 47. UAE 23-Valent Pneumococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2016-2027
Figure 48. Global 23-Valent Pneumococcal Polysaccharide Vaccine Production Capacity (K Dose), 2016-2027
Figure 49. The Percentage of Production 23-Valent Pneumococcal Polysaccharide Vaccine by Region, 2020 VS 2027
Figure 50. 23-Valent Pneumococcal Polysaccharide Vaccine Industry Value Chain
Figure 51. Marketing Channels
Figure 1. 23-Valent Pneumococcal Polysaccharide Vaccine Segment by Type
Figure 2. 23-Valent Pneumococcal Polysaccharide Vaccine Segment by Application
Figure 3. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue, 2016-2027 (US$, Mn)
Figure 7. 23-Valent Pneumococcal Polysaccharide Vaccine Sales in Global Market: 2016-2027 (K Dose)
Figure 8. The Top 3 and 5 Players Market Share by 23-Valent Pneumococcal Polysaccharide Vaccine Revenue in 2020
Figure 9. By Type - Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share, 2016-2027
Figure 10. By Type - Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share, 2016-2027
Figure 11. By Type - Global 23-Valent Pneumococcal Polysaccharide Vaccine Price (USD/Dose), 2016-2027
Figure 12. By Application - Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share, 2016-2027
Figure 13. By Application - Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share, 2016-2027
Figure 14. By Application - Global 23-Valent Pneumococcal Polysaccharide Vaccine Price (USD/Dose), 2016-2027
Figure 15. By Region - Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share, 2016-2027
Figure 16. By Region - Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share, 2016-2027
Figure 17. By Country - North America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share, 2016-2027
Figure 18. By Country - North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share, 2016-2027
Figure 19. US 23-Valent Pneumococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2016-2027
Figure 20. Canada 23-Valent Pneumococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2016-2027
Figure 21. Mexico 23-Valent Pneumococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2016-2027
Figure 22. By Country - Europe 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share, 2016-2027
Figure 23. By Country - Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share, 2016-2027
Figure 24. Germany 23-Valent Pneumococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2016-2027
Figure 25. France 23-Valent Pneumococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2016-2027
Figure 26. U.K. 23-Valent Pneumococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2016-2027
Figure 27. Italy 23-Valent Pneumococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2016-2027
Figure 28. Russia 23-Valent Pneumococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2016-2027
Figure 29. Nordic Countries 23-Valent Pneumococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2016-2027
Figure 30. Benelux 23-Valent Pneumococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2016-2027
Figure 31. By Region - Asia 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share, 2016-2027
Figure 32. By Region - Asia 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share, 2016-2027
Figure 33. China 23-Valent Pneumococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2016-2027
Figure 34. Japan 23-Valent Pneumococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2016-2027
Figure 35. South Korea 23-Valent Pneumococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2016-2027
Figure 36. Southeast Asia 23-Valent Pneumococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2016-2027
Figure 37. India 23-Valent Pneumococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2016-2027
Figure 38. By Country - South America 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share, 2016-2027
Figure 39. By Country - South America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share, 2016-2027
Figure 40. Brazil 23-Valent Pneumococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2016-2027
Figure 41. Argentina 23-Valent Pneumococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2016-2027
Figure 42. By Country - Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share, 2016-2027
Figure 43. By Country - Middle East & Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share, 2016-2027
Figure 44. Turkey 23-Valent Pneumococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2016-2027
Figure 45. Israel 23-Valent Pneumococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2016-2027
Figure 46. Saudi Arabia 23-Valent Pneumococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2016-2027
Figure 47. UAE 23-Valent Pneumococcal Polysaccharide Vaccine Revenue, (US$, Mn), 2016-2027
Figure 48. Global 23-Valent Pneumococcal Polysaccharide Vaccine Production Capacity (K Dose), 2016-2027
Figure 49. The Percentage of Production 23-Valent Pneumococcal Polysaccharide Vaccine by Region, 2020 VS 2027
Figure 50. 23-Valent Pneumococcal Polysaccharide Vaccine Industry Value Chain
Figure 51. Marketing Channels
